180 related articles for article (PubMed ID: 8026711)
1. Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761), bilobalide and ginkgolide B on the electrical activity of pancreatic beta cells of normal or alloxan-diabetic mice: an ex vivo study with intracellular microelectrodes.
Vasseur M; Jean T; DeFeudis FV; Drieu K
Gen Pharmacol; 1994 Jan; 25(1):31-46. PubMed ID: 8026711
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.
Ahlemeyer B; Krieglstein J
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S8-14. PubMed ID: 13130383
[TBL] [Abstract][Full Text] [Related]
3. Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver.
Sasaki K; Hatta S; Wada K; Ueda N; Yoshimura T; Endo T; Sakata M; Tanaka T; Haga M
Life Sci; 2002 Feb; 70(14):1657-67. PubMed ID: 11991253
[TBL] [Abstract][Full Text] [Related]
4. Preventive effects of extract of leaves of ginkgo (Ginkgo biloba) and its component bilobalide on azoxymethane-induced colonic aberrant crypt foci in rats.
Suzuki R; Kohno H; Sugie S; Sasaki K; Yoshimura T; Wada K; Tanaka T
Cancer Lett; 2004 Jul; 210(2):159-69. PubMed ID: 15183531
[TBL] [Abstract][Full Text] [Related]
5. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes.
Chang TK; Chen J; Teng XW
Drug Metab Dispos; 2006 Feb; 34(2):234-42. PubMed ID: 16258077
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents.
Ahlemeyer B; Möwes A; Krieglstein J
Eur J Pharmacol; 1999 Feb; 367(2-3):423-30. PubMed ID: 10079019
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761).
Pietri S; Maurelli E; Drieu K; Culcasi M
J Mol Cell Cardiol; 1997 Feb; 29(2):733-42. PubMed ID: 9140830
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761)].
Fourtillan JB; Brisson AM; Girault J; Ingrand I; Decourt JP; Drieu K; Jouenne P; Biber A
Therapie; 1995; 50(2):137-44. PubMed ID: 7631288
[TBL] [Abstract][Full Text] [Related]
9. Isolation of bilobalide and ginkgolide A from Ginkgo biloba L. shorten the sleeping time induced in mice by anesthetics.
Wada K; Sasaki K; Miura K; Yagi M; Kubota Y; Matsumoto T; Haga M
Biol Pharm Bull; 1993 Feb; 16(2):210-2. PubMed ID: 8364459
[TBL] [Abstract][Full Text] [Related]
10. Effects of single intraperitoneal injections of an extract of Ginkgo biloba (EGb 761) and its terpene trilactone constituents on barbital-induced narcosis in the mouse.
Brochet D; Chermat R; DeFeudis FV; Drieu K
Gen Pharmacol; 1999 Sep; 33(3):249-56. PubMed ID: 10480658
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans.
Woelkart K; Feizlmayr E; Dittrich P; Beubler E; Pinl F; Suter A; Bauer R
Phytother Res; 2010 Mar; 24(3):445-50. PubMed ID: 20041430
[TBL] [Abstract][Full Text] [Related]
12. An anxiolytic-like effect of Ginkgo biloba extract and its constituent, ginkgolide-A, in mice.
Kuribara H; Weintraub ST; Yoshihama T; Maruyama Y
J Nat Prod; 2003 Oct; 66(10):1333-7. PubMed ID: 14575433
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by ginkgolides and bilobalide of the production of nitric oxide in macrophages (THP-1) but not in endothelial cells (HUVEC).
Cheung F; Siow YL; O K
Biochem Pharmacol; 2001 Feb; 61(4):503-10. PubMed ID: 11226385
[TBL] [Abstract][Full Text] [Related]
14. Bilobalide, a component of the Ginkgo biloba extract (EGb 761), protects against neuronal death in global brain ischemia and in glutamate-induced excitotoxicity.
Chandrasekaran K; Mehrabian Z; Spinnewyn B; Chinopoulos C; Drieu K; Fiskum G
Cell Mol Biol (Noisy-le-grand); 2002 Sep; 48(6):663-9. PubMed ID: 12396077
[TBL] [Abstract][Full Text] [Related]
15. Determination of ginkgolide A, B, and bilobalide in biloba L. extracts by microdialysis-HPLC.
Chiu HL; Lin HY; Yang TC
Anal Bioanal Chem; 2004 Jun; 379(3):445-8. PubMed ID: 15057504
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia.
Chandrasekaran K; Mehrabian Z; Spinnewyn B; Drieu K; Fiskum G
Brain Res; 2001 Dec; 922(2):282-92. PubMed ID: 11743961
[TBL] [Abstract][Full Text] [Related]
17. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion.
Liebgott T; Miollan M; Berchadsky Y; Drieu K; Culcasi M; Pietri S
Basic Res Cardiol; 2000 Oct; 95(5):368-77. PubMed ID: 11099163
[TBL] [Abstract][Full Text] [Related]
18. Protection of hypoxia-induced ATP decrease in endothelial cells by ginkgo biloba extract and bilobalide.
Janssens D; Michiels C; Delaive E; Eliaers F; Drieu K; Remacle J
Biochem Pharmacol; 1995 Sep; 50(7):991-9. PubMed ID: 7575684
[TBL] [Abstract][Full Text] [Related]
19. Induction of cytochrome P450s by terpene trilactones and flavonoids of the Ginkgo biloba extract EGb 761 in rats.
Deng Y; Bi HC; Zhao LZ; He F; Liu YQ; Yu JJ; Ou ZM; Ding L; Chen X; Huang ZY; Huang M; Zhou SF
Xenobiotica; 2008 May; 38(5):465-81. PubMed ID: 18421621
[TBL] [Abstract][Full Text] [Related]
20. Antioxidative activity of ginkgolides against superoxide in an aprotic environment.
Scholtyssek H; Damerau W; Wessel R; Schimke I
Chem Biol Interact; 1997 Oct; 106(3):183-90. PubMed ID: 9413545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
